Valproic acid Completed Phase 2 Trials for Rubinstein-Taybi Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01619644Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial